Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pedro González-Naranjo"'
Autor:
Pedro González-Naranjo, Concepción Pérez, Marina González-Sánchez, Adrián Gironda-Martínez, Eugenia Ulzurrun, Fernando Bartolomé, Marcos Rubio-Fernández, Angeles Martin-Requero, Nuria E. Campillo, Juan A. Páez
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 2348-2356 (2022)
Multitarget drugs are a promising therapeutic approach against Alzheimer’s disease. In this work, a new family of 5-substituted indazole derivatives with a multitarget profile including cholinesterase and BACE1 inhibition is described. Thus, the sy
Externí odkaz:
https://doaj.org/article/4413ef31a44a48d79464776ae07d0209
Autor:
Concepción Pérez, María L. de Ceballos, Pedro González-Naranjo, Fernando Bartolomé, Nuria E. Campillo, Emilio Nuñez-Borque, Alejandro Reinares-Sebastián, Juan A. Páez, Carolina Alquezar, Ángeles Martín-Requero
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
43 p.-8 fig.-2 tab.
Alzheimer's disease (AD), the leading cause of dementia in the elderly, is a neurodegenerative disorder marked by progressive impairment of cognitive ability. Patients with AD display neuropathological lesions including senil
Alzheimer's disease (AD), the leading cause of dementia in the elderly, is a neurodegenerative disorder marked by progressive impairment of cognitive ability. Patients with AD display neuropathological lesions including senil
Autor:
Juan Antonio Páez, Pedro González-Naranjo, Concepción Pérez, Marina González-Sánchez, Adrián Gironda-Martínez, Eugenia Ulzurrun, Fernando Bartolomé, Marcos Rubio-Fernández, Angeles Martin-Requero, Nuria E. Campillo
Publikováno v:
SSRN Electronic Journal.
Autor:
Javier Varela, Nuria E. Campillo, Alicia Merlino, Alicia Gómez-Barrio, José Antonio Escario, Jorge Paniagua-Solis, Mercedes González, María Laura Lavaggi, Gloria Yaluf, Hugo Cerecetto, Pedro González-Naranjo, Cristina Fonseca-Berzal, Angela Guerra, Juan A. Páez
Publikováno v:
European Journal of Medicinal Chemistry. 136:223-234
A new family of imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxide with antiproliferative Trypanosoma cruzi properties was identified from a neural network model published by our group. The synthesis and evaluation of this new class of trypanocidal agents
Autor:
Juan A. Páez, M. I. Martín-Fontelles, Concepción Pérez, Carlos Roca, María L. de Ceballos, Rocío Girón, Ángeles Martín-Requero, Gabriela Vaca, Nuria E. Campillo, Pedro González-Naranjo, Natalia Pérez-Macias, Eva Sánchez-Robles
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Multitarget cannabinoids could be a promising therapeutic strategic to fight against Alzheimer's disease. In this sense, our group has developed a new family of indazolylketones with multitarget profile including cannabinoids, cholinesterase and BACE
Autor:
Iván V. Rosado, José Antonio Pérez-Simón, Teresa Caballero-Velázquez, Pedro González-Naranjo, M. Victoria Barbado, Luis Ignacio Sánchez-Abarca, Mayte Medrano, Jesús Martín-Sánchez, Estefania Garcia-Guerrero, Isabel Álvarez-Laderas, Juan A. Páez, Nuria E. Campillo, José I. Piruat
Publikováno v:
International Journal of Cancer. 140:674-685
Although hematopoietic and immune system show high levels of the cannabinoid receptor CB2, the potential effect of cannabinoids on hematologic malignancies has been poorly determined. Here we have investigated their anti-tumor effect in multiple myel
Autor:
Carolina Alquézar, Patricia Del Cerro, Eva Carro, Concepción Pérez, Pedro González-Naranjo, Nuria E. Campillo, Juan A. Páez, Fernando Bartolome, Ángeles Martín-Requero
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
43 p.-6 fig.-3 tab. BACKGROUND:Alzheimer's disease is a multifactorial disorder for which there is no disease-modifying treatment yet. CB2 receptors have emerged as a promising therapeutic target for Alzheimer's disease because they are expressed in
Autor:
Hugo Cerecetto, Nuria E. Campillo, Juan A. Páez, Pedro González-Naranjo, Angela Guerra, Mercedes González
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
ResearcherID
Scopus-Elsevier
instname
ResearcherID
Scopus-Elsevier
A supervised artificial neural network model has been developed for the accurate prediction of the anti-T. cruzi activity of heterogeneous series of compounds. A representative set of 72 compounds of wide structural diversity was chosen in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c964b023b8ee502d59453387582490f2
http://hdl.handle.net/10261/95347
http://hdl.handle.net/10261/95347
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nuñez-Borque, Emilio, González-Naranjo, Pedro, Bartolomé, Fernando, Alquézar, Carolina, Reinares-Sebastián, Alejandro, Pérez, Concepción, Ceballos, Maria L., Páez, Juan A., Campillo, Nuria E., Martín-Requero, Ángeles
Publikováno v:
Molecular Neurobiology; Apr2020, Vol. 57 Issue 4, p1938-1951, 14p